Antitumor effect of interleukin-2 against renal cell carcinoma

M. Oya, K. Marumo, H. Tazaki

研究成果: Article査読

抄録

Renal cell carcinoma (RCC) is one of the most insensitive urologic tumors to either radiotherapy or anticancer chemotherapy. Several reports have shown that interferon (IFN) is the agent of great promise to treat advanced RCC. However, the effectiveness of IFN is limited.1) Eighteen patients with advanced RCC were treated by IL2. Antitumor effects were evaluated according to immunological parameters and survival rates.

本文言語English
ページ(範囲)129-130
ページ数2
ジャーナルAnnals of Cancer Research and Therapy
2
1
DOI
出版ステータスPublished - 1993

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究
  • 薬理学(医学)

フィンガープリント

「Antitumor effect of interleukin-2 against renal cell carcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル